NFE2L2 and irritable bowel syndrome: Compared with PI-IBS group, treatment of ALW-II-41-27 (25 μg/kg) significantly increased the level of nuclear Nrf2 and remarkably reduced the nuclear translocation of NF-κB in colon of ALW-II-41-27-treated mice (P < 0.01).